![]() |
|
|
Vol. 18, Issue 3, 743-754, March 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




Departments of *Biochemistry and Molecular Biology and
Cell and Developmental Biology, Oregon Health & Science University, Portland, OR 97239
Submitted September 8, 2006;
Revised November 17, 2006;
Accepted December 3, 2006
Monitoring Editor: Jean Gruenberg
Transferrin receptor 2 (TfR2) is a homologue of transferrin receptor 1 (TfR1), the protein that delivers iron to cells through receptor-mediated endocytosis of diferric transferrin (Fe2Tf). TfR2 also binds Fe2Tf, but it seems to function primarily in the regulation of systemic iron homeostasis. In contrast to TfR1, the trafficking of TfR2 within the cell has not been extensively characterized. Previously, we showed that Fe2Tf increases TfR2 stability, suggesting that trafficking of TfR2 may be regulated by interaction with its ligand. In the present study, therefore, we sought to identify the mode of TfR2 degradation, to characterize TfR2 trafficking, and to determine how Fe2Tf stabilizes TfR2. Stabilization of TfR2 by bafilomycin implies that TfR2 traffics to the lysosome for degradation. Confocal microscopy reveals that treatment of cells with Fe2Tf increases the fraction of TfR2 localizing to recycling endosomes and decreases the fraction of TfR2 localizing to late endosomes. Mutational analysis of TfR2 shows that the mutation G679A, which blocks TfR2 binding to Fe2Tf, increases the rate of receptor turnover and prevents stabilization by Fe2Tf, indicating a direct role of Fe2Tf in TfR2 stabilization. The mutation Y23A in the cytoplasmic domain of TfR2 inhibits its internalization and degradation, implicating YQRV as an endocytic motif.
Address correspondence to: Caroline A. Enns (ennsca{at}ohsu.edu)
Abbreviations used: Ab, antibody; AP, adaptor protein; EEA, early endosomal antigen; FBS, fetal bovine serum; Fe2Tf, diferric transferrin; HBSS, Hanks' balanced salt solution; LAMP, lysosome-associated membrane protein; MEM, minimal essential medium; PBS, phosphate-buffered saline; Tf, transferrin; TfR, transferrin receptor; Trfr2, murine transferrin receptor 2; TGN, trans-Golgi network; WT, wild-type; YXXØ, tyrosine (Y)-based endocytic motif where X represents any amino acid and Ø represents a bulky hydrophobic residue.
This article has been cited by other articles:
![]() |
C. E. Herbison, K. Thorstensen, A. C. G. Chua, R. M. Graham, P. Leedman, J. K. Olynyk, and D. Trinder The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells Am J Physiol Cell Physiol, December 1, 2009; 297(6): C1567 - C1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-S. Zhang and C. A. Enns Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control Mechanisms J. Biol. Chem., January 9, 2009; 284(2): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Robinson, L. Jiang, and K. Schumacher The Endosomal System of Plants: Charting New and Familiar Territories Plant Physiology, August 1, 2008; 147(4): 1482 - 1492. [Full Text] [PDF] |
||||
![]() |
N. C. Andrews Forging a field: the golden age of iron biology Blood, July 15, 2008; 112(2): 219 - 230. [Full Text] [PDF] |
||||
![]() |
D. F. Wallace, L. Summerville, E. M. Crampton, and V. N. Subramaniam Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis Am J Physiol Cell Physiol, February 1, 2008; 294(2): C383 - C390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Fleming The Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism Hematology, January 1, 2008; 2008(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, M. Chloupkova, J. Gao, T. L. Chapman-Arvedson, and C. A. Enns HFE Modulates Transferrin Receptor 2 Levels in Hepatoma Cells via Interactions That Differ from Transferrin Receptor 1-HFE Interactions J. Biol. Chem., December 21, 2007; 282(51): 36862 - 36870. [Abstract] [Full Text] [PDF] |
||||